Abstract: Optimization of nearest-neighbor feature selection depends on the number of samples and features, the type of statistical effect, the feature scoring algorithm, and class imbalance. We ...
WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...
The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.
While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...
President Trump called Commissioner Marty Makary to the White House to discuss his frustration with the agency handling of vaccine issues, sources told POLITICO.
The US Food and Drug Administration will now review Moderna’s new, messenger RNA–based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.
The Food and Drug Administration will review the investigational seasonal flu vaccine candidate after rejecting it earlier ...
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...
Moderna (MNRNA) stock rises as FDA accepts mRNA-1010 flu vaccine BLA, setting Aug. 5, 2026 action date. Read more here.
Singular Genomics Launches G4X (TM) in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications ...
Release summary: Molecular Instruments launches fully ambient-temperature HCR (TM) Pro RNA-ISH on the BOND-III, marking a new generation of clinical-grade RNA-ISH designed to reduce heat-driven ...
The firm originally submitted a new drug application seeking approval of the drug in 2016, which was rejected, and, in 2024, resubmitted an application.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results